2 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
Follow LM103 TILs Injection: new trials by email Literature Review of LM103 TILs Injection trials Research Report on LM103 TILs Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II Trial of LM103 for Adjuvant Treatment in Patients With Non-small Cell Lung Cancer LM103 TILs Injection, PD-1 / PD-L1 monoclonal antibody - Non-Small Cell Lung Cancer | Phase 2 | Recruiting | Suzhou BlueHorse Therapeutics Co., Ltd. | 45 | 2026-02-26 | 2026-05-13 |
| A Phase II Trial of LM103 in Advanced Melanoma LM103 TILs Injection, Dacarbazine, temozolomide, paclitaxel, carboplatin/cisplatin - Advanced Melanoma | Phase 2 | Recruiting | Suzhou BlueHorse Therapeutics Co., Ltd. | 92 | 2025-12-16 | 2026-08-31 |
Carcinoma, Non-Small-Cell Lung (1)
Suzhou BlueHorse Therapeutics Co., Ltd. (2)
China (2)
Yilong Wu (1)